subject: Medicare and FDA Work Side-by-Side on New Pilot Project [print this page] Still analysts agree that how this new process would affect medical companies is unclear and is likely to be met with "cautious optimism." It all depends on how the plan is structured and whether it is voluntary. A Medicare coverage decision often can make or break a drug, device or medical procedure. And whether this new collaboration would lead to speedier insurance coverage or higher sales is anyone's guess.
Medicare and FDA Work Side-by-Side on New Pilot Project
